Explore our comprehensive coverage of fda approval, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA's accelerated approval of a $1.2 million CRISPR base-editing therapy for Alzheimer's, coupled with emerging safety data on epigenetic drift, i...
Read Full Story →
Medical ResearchThe FDA's approval of the first in vivo base-editing therapy for cardiovascular risk marks a definit...
Medical ResearchThe FDA's accelerated approval of the first personalized mRNA cancer vaccine for high-risk melanoma,...
Medical ResearchThe convergence of multiplex metabolic agonists, in vivo CRISPR editing, and AI-driven clinical mode...
Mental HealthThe mental health sector is undergoing a structural realignment driven by at-home neuromodulation, A...
Medical ResearchThe FDA's approval of an in vivo CRISPR therapy and the NIH's pivot to AI-validated trials represent...
Medical ResearchThe FDA's approval of the first AI-designed neurodegenerative drug and Phase 3 CRISPR data marks a d...
